Daunorubicin

Cat. No.: IBDI-430920

Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor.

Product Details

Target	TopoisomeRase | DNA/RNA Synthesis | ADC Cytotoxin | Autophagy | Bacterial | Antibiotic | Apoptosis
Molecular Weight	527.52
Synonyms	Daunomycin, RP 13057, Rubidomycin
SMILES	O=C(C(C(OC)=CC=C1)=C1C2=O)C3=C2C(O)=C(C[[email protected]@](O)(C(C)=O)C[[email protected]@H]4O[[email protected]@]5([H])C[[email protected]](N)[[email protected]](O)[[email protected]](C)O5)C4=C3O
Structure Classification	Quinones>Anthraquinones Phenols>Polyphenols

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.